Clinical Trial Update: Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors [NA]

View source ↗

Summary

A clinical trial evaluating exercise to target metabolic dysregulation in stage I-III breast and prostate cancer survivors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Prostate Cancer

Snippet

Sponsor: University of Southern California | Conditions: Cancer Survivor, No Evidence of Disease | NA | Status: TERMINATED